Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
10.69
0.00 (0.00%)
Apr 25, 2024, 3:58 PM EDT - Market closed
Company Description
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
Country | United States |
Founded | 2020 |
IPO Date | Feb 10, 2023 |
Industry | Shell Companies |
Sector | Financials |
CEO | Kuk Hyoun Hwang |
Contact Details
Address: 10900 Ne 4th Street, Suite 2300 Bellevue, Washington 98004 United States | |
Phone | 425-635-7700 |
Stock Details
Ticker Symbol | BLAC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0001840425 |
ISIN Number | US0791741087 |
Employer ID | 84-5052822 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Kuk Hyoun Hwang | Chief Executive Officer and Director |
David Jin Yoo | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 22, 2024 | 8-K | Current Report |
Apr 17, 2024 | 10-K | Annual Report |
Apr 16, 2024 | PRE 14A | Other preliminary proxy statements |
Apr 11, 2024 | 8-K | Current Report |
Apr 2, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 13, 2024 | 8-K | Current Report |
Feb 21, 2024 | 8-K | Current Report |
Feb 13, 2024 | 8-K | Current Report |
Feb 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |